These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 12681003
1. Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. Doose DR, Wang SS, Padmanabhan M, Schwabe S, Jacobs D, Bialer M. Epilepsia; 2003 Apr; 44(4):540-9. PubMed ID: 12681003 [Abstract] [Full Text] [Related]
2. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Rosenfeld WE, Doose DR, Walker SA, Nayak RK. Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594 [Abstract] [Full Text] [Related]
3. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives. Sinofsky FE, Pasquale SA. Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490 [Abstract] [Full Text] [Related]
4. The interaction between St John's wort and an oral contraceptive. Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, Gorski JC. Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455 [Abstract] [Full Text] [Related]
5. Evaluation of interaction between fluconazole and an oral contraceptive in healthy women. Hilbert J, Messig M, Kuye O, Friedman H. Obstet Gynecol; 2001 Aug; 98(2):218-23. PubMed ID: 11506836 [Abstract] [Full Text] [Related]
13. Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential. LoRusso PM, Piha-Paul SA, Mita M, Colevas AD, Malhi V, Colburn D, Yin M, Low JA, Graham RA. Cancer Chemother Pharmacol; 2013 Jan; 71(1):193-202. PubMed ID: 23064958 [Abstract] [Full Text] [Related]
14. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone. Hendrix CW, Jackson KA, Whitmore E, Guidos A, Kretzer R, Liss CM, Shah LP, Khoo KC, McLane J, Trapnell CB. Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059 [Abstract] [Full Text] [Related]
15. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S, Mishell DR, Gray G, Dozono-Takano R, Brenner PF, Eide I, de Quattro V, Shaw ST. Am J Obstet Gynecol; 1980 Apr 01; 136(7):920-31. PubMed ID: 6767404 [Abstract] [Full Text] [Related]
16. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive. Barditch-Crovo P, Trapnell CB, Ette E, Zacur HA, Coresh J, Rocco LE, Hendrix CW, Flexner C. Clin Pharmacol Ther; 1999 Apr 01; 65(4):428-38. PubMed ID: 10223781 [Abstract] [Full Text] [Related]
17. Pharmacokinetics of three bioequivalent norethindrone/mestranol-50 micrograms and three norethindrone/ethinyl estradiol-35 micrograms OC formulations: are "low-dose" pills really lower? Brody SA, Turkes A, Goldzieher JW. Contraception; 1989 Sep 01; 40(3):269-84. PubMed ID: 2766722 [Abstract] [Full Text] [Related]
20. The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir. Garg V, van Heeswijk R, Yang Y, Kauffman R, Smith F, Adda N. J Clin Pharmacol; 2012 Oct 01; 52(10):1574-83. PubMed ID: 22039291 [Abstract] [Full Text] [Related] Page: [Next] [New Search]